Skip to main content
Top
Published in: Breast Cancer Research 2/2014

Open Access 01-04-2014 | Research article

Mammographic texture resemblance generalizes as an independent risk factor for breast cancer

Authors: Mads Nielsen, Celine M Vachon, Christopher G Scott, Konstantin Chernoff, Gopal Karemore, Nico Karssemeijer, Martin Lillholm, Morten A Karsdal

Published in: Breast Cancer Research | Issue 2/2014

Login to get access

Abstract

Introduction

Breast density has been established as a major risk factor for breast cancer. We have previously demonstrated that mammographic texture resemblance (MTR), recognizing the local texture patterns of the mammogram, is also a risk factor for breast cancer, independent of percent breast density. We examine if these findings generalize to another population.

Methods

Texture patterns were recorded in digitalized pre-diagnosis (3.7 years) film mammograms of a nested case–control study within the Dutch screening program (S1) comprising of 245 breast cancers and 250 matched controls. The patterns were recognized in the same study using cross-validation to form resemblance scores associated with breast cancer. Texture patterns from S1 were examined in an independent nested case–control study within the Mayo Mammography Health Study cohort (S2) of 226 cases and 442 matched controls: mammograms on average 8.5 years prior to diagnosis, risk factor information and percent mammographic density (PD) estimated using Cumulus were available. MTR scores estimated from S1, S2 and S1 + S2 (the latter two as cross-validations) were evaluated in S2. MTR scores were analyzed as both quartiles and continuously for association with breast cancer using odds ratios (OR) and adjusting for known risk factors including age, body mass index (BMI), and hormone usage.

Results

The mean ages of S1 and S2 were 58.0 ± 5.7 years and 55.2 ± 10.5 years, respectively. The MTR scores on S1 showed significant capability to discriminate cancers from controls (area under the operator characteristics curve (AUC) = 0.63 ± 0.02, P <0.001), which persisted after adjustment for PD. S2 showed an AUC of 0.63, 0.61, and 0.60 based on PD, MTR scores trained on S2, and MTR scores trained on S1, respectively. When adjusted for PD, MTR scores of S2 trained on S1 showed an association with breast cancer for the highest quartile alone: OR in quartiles of controls as reference; 1.04 (0.59 to 1.81); 0.95 (0.52 to 1.74); 1.84 (1.10 to 3.07) respectively. The combined continuous model with both PD and MTR scores based on S1 had an AUC of 0.66 ± 0.03.

Conclusions

The local texture patterns associated with breast cancer risk in S1 were also an independent risk factor in S2. Additional textures identified in S2 did not significantly improve risk segregation. Hence, the textural patterns that indicated elevated risk persisted under differences in X-ray technology, population demographics, follow-up time and geography.
Appendix
Available only for authorised users
Literature
2.
go back to reference Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K: Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006, 98: 1204-1214. 10.1093/jnci/djj331.CrossRefPubMed Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K: Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006, 98: 1204-1214. 10.1093/jnci/djj331.CrossRefPubMed
3.
go back to reference Tice JA, Cummings SR, Ziv E, Kerlikowske K: Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat. 2005, 94: 115-122. 10.1007/s10549-005-5152-4.CrossRefPubMed Tice JA, Cummings SR, Ziv E, Kerlikowske K: Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat. 2005, 94: 115-122. 10.1007/s10549-005-5152-4.CrossRefPubMed
4.
go back to reference Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ: Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007, 356: 227-236. 10.1056/NEJMoa062790.CrossRefPubMed Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ: Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007, 356: 227-236. 10.1056/NEJMoa062790.CrossRefPubMed
5.
go back to reference Vachon CM, Sellers TA, Pankratz VS: Mammographic density of the breast. N Engl J Med. 2003, 348: 174-175. author reply 174–175CrossRefPubMed Vachon CM, Sellers TA, Pankratz VS: Mammographic density of the breast. N Engl J Med. 2003, 348: 174-175. author reply 174–175CrossRefPubMed
6.
go back to reference Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM: Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case–control study. J Natl Cancer Inst. 2011, 103: 744-752. 10.1093/jnci/djr079.CrossRefPubMed Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM: Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case–control study. J Natl Cancer Inst. 2011, 103: 744-752. 10.1093/jnci/djr079.CrossRefPubMed
7.
go back to reference van Engeland S, Snoeren PR, Huisman H, Boetes C, Karssemeijer N: Volumetric breast density estimation from full-field digital mammograms. IEEE Trans Medical Imaging. 2006, 25: 273-282.CrossRefPubMed van Engeland S, Snoeren PR, Huisman H, Boetes C, Karssemeijer N: Volumetric breast density estimation from full-field digital mammograms. IEEE Trans Medical Imaging. 2006, 25: 273-282.CrossRefPubMed
8.
go back to reference Lokate M, Kallenberg MG, Karssemeijer N, Van den Bosch MA, Peeters PH, Van Gils CH: Volumetric breast density from full-field digital mammograms and its association with breast cancer risk factors: a comparison with a threshold method. Cancer Epidemiol Biomarkers Prev. 2010, 19: 3096-3105. 10.1158/1055-9965.EPI-10-0703.CrossRefPubMed Lokate M, Kallenberg MG, Karssemeijer N, Van den Bosch MA, Peeters PH, Van Gils CH: Volumetric breast density from full-field digital mammograms and its association with breast cancer risk factors: a comparison with a threshold method. Cancer Epidemiol Biomarkers Prev. 2010, 19: 3096-3105. 10.1158/1055-9965.EPI-10-0703.CrossRefPubMed
9.
go back to reference Manduca A, Carston MJ, Heine JJ, Scott CG, Pankratz VS, Brandt KR, Sellers TA, Vachon CM, Cerhan JR: Texture features from mammographic images and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009, 18: 837-845. 10.1158/1055-9965.EPI-08-0631.CrossRefPubMedPubMedCentral Manduca A, Carston MJ, Heine JJ, Scott CG, Pankratz VS, Brandt KR, Sellers TA, Vachon CM, Cerhan JR: Texture features from mammographic images and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009, 18: 837-845. 10.1158/1055-9965.EPI-08-0631.CrossRefPubMedPubMedCentral
10.
go back to reference Nielsen M, Karemore G, Loog M, Raundahl J, Karssemeijer N, Otten JD, Karsdal MA, Vachon CM, Christiansen C: A novel and automatic mammographic texture resemblance marker is an independent risk factor for breast cancer. Cancer Epidemiol. 2010, 35: 381-387.CrossRefPubMed Nielsen M, Karemore G, Loog M, Raundahl J, Karssemeijer N, Otten JD, Karsdal MA, Vachon CM, Christiansen C: A novel and automatic mammographic texture resemblance marker is an independent risk factor for breast cancer. Cancer Epidemiol. 2010, 35: 381-387.CrossRefPubMed
11.
go back to reference Wei J, Chan HP, Wu YT, Zhou C, Helvie MA, Tsodikov A, Hadjiiski LM, Sahiner B: Association of computerized mammographic parenchymal pattern measure with breast cancer risk: a pilot case–control study. Radiology. 2011, 260: 42-49. 10.1148/radiol.11101266.CrossRefPubMedPubMedCentral Wei J, Chan HP, Wu YT, Zhou C, Helvie MA, Tsodikov A, Hadjiiski LM, Sahiner B: Association of computerized mammographic parenchymal pattern measure with breast cancer risk: a pilot case–control study. Radiology. 2011, 260: 42-49. 10.1148/radiol.11101266.CrossRefPubMedPubMedCentral
12.
go back to reference Heine JJ, Cao K, Rollison DE, Tiffenberg G, Thomas JA: A quantitative description of the percentage of breast density measurement using full-field digital mammography. Acad Radiol. 2011, 18: 556-564. 10.1016/j.acra.2010.12.015.CrossRefPubMedPubMedCentral Heine JJ, Cao K, Rollison DE, Tiffenberg G, Thomas JA: A quantitative description of the percentage of breast density measurement using full-field digital mammography. Acad Radiol. 2011, 18: 556-564. 10.1016/j.acra.2010.12.015.CrossRefPubMedPubMedCentral
13.
go back to reference Heine JJ, Scott CG, Sellers TA, Brandt KR, Serie DJ, Wu FF, Morton MJ, Schueler BA, Couch FJ, Olson JE, Pankratz VS, Vachon CM: A novel automated mammographic density measure and breast cancer risk. J Natl Cancer Inst. 2012, 104: 1028-1037. 10.1093/jnci/djs254.CrossRefPubMedPubMedCentral Heine JJ, Scott CG, Sellers TA, Brandt KR, Serie DJ, Wu FF, Morton MJ, Schueler BA, Couch FJ, Olson JE, Pankratz VS, Vachon CM: A novel automated mammographic density measure and breast cancer risk. J Natl Cancer Inst. 2012, 104: 1028-1037. 10.1093/jnci/djs254.CrossRefPubMedPubMedCentral
14.
go back to reference Li H, Giger ML, Olopade OI, Margolis A, Lan L, Chinander MR: Computerized texture analysis of mammographic parenchymal patterns of digitized mammograms. Acad Radiol. 2005, 12: 863-873. 10.1016/j.acra.2005.03.069.CrossRefPubMed Li H, Giger ML, Olopade OI, Margolis A, Lan L, Chinander MR: Computerized texture analysis of mammographic parenchymal patterns of digitized mammograms. Acad Radiol. 2005, 12: 863-873. 10.1016/j.acra.2005.03.069.CrossRefPubMed
15.
go back to reference Olson JE, Sellers TA, Scott CG, Schueler BA, Brandt KR, Serie DJ, Jensen MR, Wu FF, Morton MJ, Heine JJ, Couch FJ, Pankratz VS, Vachon CM: The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo mammography health study cohort. Breast Cancer Res. 2012, 14: R147-10.1186/bcr3357.CrossRefPubMedPubMedCentral Olson JE, Sellers TA, Scott CG, Schueler BA, Brandt KR, Serie DJ, Jensen MR, Wu FF, Morton MJ, Heine JJ, Couch FJ, Pankratz VS, Vachon CM: The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo mammography health study cohort. Breast Cancer Res. 2012, 14: R147-10.1186/bcr3357.CrossRefPubMedPubMedCentral
16.
go back to reference Otten JD, Karssemeijer N, Hendriks JH, Groenewoud JH, Fracheboud J, Verbeek AL, de Koning HJ, Holland R: Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst. 2005, 97: 748-754. 10.1093/jnci/dji131.CrossRefPubMed Otten JD, Karssemeijer N, Hendriks JH, Groenewoud JH, Fracheboud J, Verbeek AL, de Koning HJ, Holland R: Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst. 2005, 97: 748-754. 10.1093/jnci/dji131.CrossRefPubMed
17.
go back to reference Raundahl J, Loog M, Pettersen P, Nielsen M: Quantifying effect-specific mammographic density. Med Image Comput Comput Assist Interv. 2007, 10: 580-587.PubMed Raundahl J, Loog M, Pettersen P, Nielsen M: Quantifying effect-specific mammographic density. Med Image Comput Comput Assist Interv. 2007, 10: 580-587.PubMed
18.
go back to reference Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis of mammographic densities. Phys Med Biol. 1994, 39: 1629-1638. 10.1088/0031-9155/39/10/008.CrossRefPubMed Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis of mammographic densities. Phys Med Biol. 1994, 39: 1629-1638. 10.1088/0031-9155/39/10/008.CrossRefPubMed
19.
go back to reference Raundahl J, Loog M, Pettersen P, Tanko LB, Nielsen M: Automated effect-specific mammographic pattern measures. IEEE Trans Med Imaging. 2008, 27: 1054-1060.CrossRefPubMed Raundahl J, Loog M, Pettersen P, Tanko LB, Nielsen M: Automated effect-specific mammographic pattern measures. IEEE Trans Med Imaging. 2008, 27: 1054-1060.CrossRefPubMed
20.
go back to reference Sporring J: Gaussian scale-space theory. 1997, Dordrecht, Boston: Kluwer Academic PublishersCrossRef Sporring J: Gaussian scale-space theory. 1997, Dordrecht, Boston: Kluwer Academic PublishersCrossRef
21.
go back to reference Beijerinck D, van Noord PA, Kemmeren JM, Seidell JC: Breast size as a determinant of breast cancer. Int J Obes Relat Metab Disord. 1995, 19: 202-205.PubMed Beijerinck D, van Noord PA, Kemmeren JM, Seidell JC: Breast size as a determinant of breast cancer. Int J Obes Relat Metab Disord. 1995, 19: 202-205.PubMed
22.
go back to reference Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH: Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2634-2640. 10.1158/1055-9965.EPI-05-0824.CrossRefPubMed Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH: Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2634-2640. 10.1158/1055-9965.EPI-05-0824.CrossRefPubMed
23.
go back to reference Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R: Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer. 2002, 95: 2455-2464. 10.1002/cncr.10984.CrossRefPubMed Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R: Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer. 2002, 95: 2455-2464. 10.1002/cncr.10984.CrossRefPubMed
24.
go back to reference Nielsen M, Pettersen PC, Alexandersen P, Karemore G, Raundahl J, Loog M, Christiansen C: Breast density changes associated with postmenopausal hormone therapy: post hoc radiologist- and computer-based analyses. Menopause. 2010, 17: 772-778.PubMed Nielsen M, Pettersen PC, Alexandersen P, Karemore G, Raundahl J, Loog M, Christiansen C: Breast density changes associated with postmenopausal hormone therapy: post hoc radiologist- and computer-based analyses. Menopause. 2010, 17: 772-778.PubMed
25.
go back to reference Nielsen M, Raundahl J, Pettersen PC, Loog M, Karemore G, Karsdal MA, Christiansen C: Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene. Menopause. 2009, 16: 785-791. 10.1097/GME.0b013e318199d07f.CrossRefPubMed Nielsen M, Raundahl J, Pettersen PC, Loog M, Karemore G, Karsdal MA, Christiansen C: Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene. Menopause. 2009, 16: 785-791. 10.1097/GME.0b013e318199d07f.CrossRefPubMed
26.
go back to reference Leeming DJ, Bay-Jensen AC, Vassiliadis E, Larsen MR, Henriksen K, Karsdal MA: Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development. Biomarkers. 2011, 16: 193-205. 10.3109/1354750X.2011.557440.CrossRefPubMed Leeming DJ, Bay-Jensen AC, Vassiliadis E, Larsen MR, Henriksen K, Karsdal MA: Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development. Biomarkers. 2011, 16: 193-205. 10.3109/1354750X.2011.557440.CrossRefPubMed
27.
go back to reference Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol. 1997, 137: 231-245. 10.1083/jcb.137.1.231.CrossRefPubMedPubMedCentral Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol. 1997, 137: 231-245. 10.1083/jcb.137.1.231.CrossRefPubMedPubMedCentral
28.
go back to reference Radisky DC, Bissell MJ: Cancer. Respect thy neighbor!. Science. 2004, 303: 775-777. 10.1126/science.1094412.CrossRefPubMed Radisky DC, Bissell MJ: Cancer. Respect thy neighbor!. Science. 2004, 303: 775-777. 10.1126/science.1094412.CrossRefPubMed
29.
go back to reference Leeming DJ, Hegele A, Byrjalsen I, Hofmann R, Qvist P, Karsdal MA, Schrader AJ, Wagner R, Olbert P: Biochemical markers for monitoring response to therapy: evidence for higher bone specificity by a novel marker compared with routine markers. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1269-1276. 10.1158/1055-9965.EPI-07-2697.CrossRefPubMed Leeming DJ, Hegele A, Byrjalsen I, Hofmann R, Qvist P, Karsdal MA, Schrader AJ, Wagner R, Olbert P: Biochemical markers for monitoring response to therapy: evidence for higher bone specificity by a novel marker compared with routine markers. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1269-1276. 10.1158/1055-9965.EPI-07-2697.CrossRefPubMed
30.
go back to reference Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R: Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst. 2007, 99: 386-395. 10.1093/jnci/djk066.CrossRefPubMed Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R: Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst. 2007, 99: 386-395. 10.1093/jnci/djk066.CrossRefPubMed
Metadata
Title
Mammographic texture resemblance generalizes as an independent risk factor for breast cancer
Authors
Mads Nielsen
Celine M Vachon
Christopher G Scott
Konstantin Chernoff
Gopal Karemore
Nico Karssemeijer
Martin Lillholm
Morten A Karsdal
Publication date
01-04-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 2/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3641

Other articles of this Issue 2/2014

Breast Cancer Research 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine